Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company is headquartered in Englewood, Colorado and currently employs 6 full-time employees. The company went IPO on 2011-05-19. The firm is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2023
09/30/2023
06/30/2023
03/31/2023
12/31/2022
Revenue
0
0
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
--
--
Cost of Revenue
--
--
--
--
--
--
Gross Profit
--
--
--
--
--
--
Selling, General & Admin
7
0
1
1
3
1
Research & Development
2
1
0
0
0
0
Operating Expenses
9
2
1
1
4
2
Other Non Operating Income (Expenses)
0
0
0
0
0
--
Pretax Income
-8
-2
-1
-1
-3
-2
Income Tax Expense
--
--
--
--
--
--
Net Income
-8
-2
-1
-1
-3
-2
Net Income Growth
-50%
0%
-83%
-50%
-40%
-67%
Shares Outstanding (Diluted)
0.82
0.82
0.8
0.75
0.75
0.75
Shares Change (YoY)
10%
10%
7%
0%
0%
10%
EPS (Diluted)
-10.42
-2.48
-1.52
-1.82
-5.3
-2.95
EPS Growth
-52%
-16%
-82%
-34%
-30%
-68%
Free Cash Flow
-8
-2
0
-3
-2
-4
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
--
--
--
--
--
--
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
0%
0%
0%
EBITDA
-9
-2
-1
-1
-4
-2
EBITDA Margin
0%
0%
0%
0%
0%
0%
D&A For EBITDA
0
0
0
0
0
0
EBIT
-9
-2
-1
-1
-4
-2
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
--
--
--
--
--
--
Follow-Up Questions
What are Ampio Pharmaceuticals Inc's key financial statements?
According to the latest financial statement (Form-10K), Ampio Pharmaceuticals Inc has a total asset of $0, Net loss of $0
What are the key financial ratios for AMPE?
Ampio Pharmaceuticals Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Ampio Pharmaceuticals Inc's revenue broken down by segment or geography?
Ampio Pharmaceuticals Inc largest revenue segment is Baseball, at a revenue of 635,060,000 in the most earnings release.For geography, United States is the primary market for Ampio Pharmaceuticals Inc, at a revenue of 732,492,000.
Is Ampio Pharmaceuticals Inc profitable?
no, according to the latest financial statements, Ampio Pharmaceuticals Inc has a net loss of $0
Does Ampio Pharmaceuticals Inc have any liabilities?
no, Ampio Pharmaceuticals Inc has liability of 0
How many outstanding shares for Ampio Pharmaceuticals Inc?
Ampio Pharmaceuticals Inc has a total outstanding shares of 0